66 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
) date of hire, (viii) annual base salary or hourly wage rate (as applicable), (ix) bonuses, and (x) whether such Company Employee is on a work visa … , or (B) hire any replacement for any Company Employee who is terminated or resigns prior to the Closing;
(xviii) (A) cause the Company to engage
424B3
kulv5jj42w1im7yaz
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
69ltae5cadn1buprg5at
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
wdycxi
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
ovr6 gbu0zitb
16 Jun 23
Business combination disclosure
5:17pm
425
88a xx91p6f9kahgn
16 Jun 23
Business combination disclosure
5:16pm
425
k46fszge2dq8vn24 bz
16 Jun 23
Business combination disclosure
5:14pm
425
k4p3r45k
16 Jun 23
Business combination disclosure
5:14pm
425
h2zzv8w
16 Jun 23
Business combination disclosure
5:12pm
425
sfqlgk9
16 Jun 23
Business combination disclosure
5:11pm
425
b8nag0i ff8fwblam8y
16 Jun 23
Business combination disclosure
8:08am
425
6gdagnv0jt1v50
16 Jun 23
Business combination disclosure
7:09am
8-K
sfhz nnlx6a
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-2.1
ker5q 4zvzgffpn67e
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-99.1
vwa23wr89kx7
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am